In vivo molecular imaging techniques is increasingly used in the management of oncological patients, allowing different aspects of oncological pathologies to be assessed (e.g. metabolism, hypoxia) non invasively. The possibility to extract indexes of disease from in vivo biomedical images and to associate them with their biological drivers opens new prospective on the role of in vivo molecular imaging and expedites the translation of novel biomarkers from the bench to the clinical environment. In this work we investigate the relationship between 18 F-FDG uptake measured by BodyWeight Standardized Uptake Value (SUV BW ) as index of cell glucose metabolism, and histological indices for gastric and gastro-oesophageal cancer. For this purpose, Partial Volume Effect Correction (PVC) has been properly compensated prior to the measurement of the PET index (PVC-SUV BW ). The correlation of 18 F-FDG PVC-SUV BW with histology data was evaluated by bivariate and multivariate statistical analysis. Although obtained in a limited number of patients, our results suggest that correlations can be found when PVC is applied to SUV BW and that 18 F-FDG PET can provide information on biological characteristics of gastric and gastro-oesophageal cancer lesions.
Introduction
In vivo disease biomarkers are increasingly demanded by clinicians in order to characterize a disease, to make prognosis and to predict response to treatment non invasively.
Body-Weight Standardized Uptake Value (SUV BW ), measured by Fluorodeoxyglucose and Positron Emission Tomography ( 18 F-FDG PET), has been extensively used as semi-quantitative index accounting for altered glucose metabolism of an oncological lesion. In order to obtain an accurate measurement of 18 F-FDG SUV BW , a Correction for Partial Volume Effect (PVC) has been proved mandatory, since this effect causes severe underestimation of SUV BW (up to 80% -90% for small lesions) [1, 2] .
Aim of this work was to evaluate the metabolic impact of PVC on SUV BW as potential in vivo prognostic biomarker of gastric and gastro-oesophageal cancer, reflecting ex vivo histo-pathological characteristics.
Materials and Methods
Fourty-nine patients (31 men, 18 women; mean age 63 ± 13 years; age range: 33 -83 years) with biopsy-proven gastric and gastro-oesophageal cancer underwent a basal 18 F-FDG PET-CT study.
18
F-FDG PET/CT sensitivity was assessed. Patient weight, and injected/residual dose were measured in order to calculate PVC-SUV BW on primitive gastric and gastro-oesophageal lesions detected on 18 F-FDG PET images.
Patients fasted for twelve hours before the exams and were intravenous injected with 18 F-FDG (1 mCi/10 kg). The PET-CT protocol began 60 minutes after the injection. All PET-CT studies were performed according to the oncological clinical protocol implemented on the discovery STE scanner, including a SCOUT scan at 40 mA, a CT scan at 140 keV and 150 mA (10 s) and 3D PET scans (2.5 min/scan) for adjacent bed positions. PET images were reconstructed by a 3D ordered subset expectation maximization algorithm (OSEM, 28 subsets, 2 iterations, 5.14 mm Gaussian post-smoothing) with corrections for random, scatter and attenuation incorporated into the iterative process.
An Operator Independent technique using an auto-matic threshold was used to define Regions of Interest (ROIs) on PET images [2] and quantitative analysis was performed by calculating mean SUV BW for each primitive gastric and gastro-oesophageal lesions. The RC-based correction methods developed in [2] was used to correct in order to account for Partial Volume Effect. Both SUV BW and PVC-SUV BW were obtained by Touch-SUV software [3, 4] .
Correlation tests (Mann-Whitney and Kruskal Wallis tests for univariate analysis and hierarchical clustering combined with a pre-processing k-means analysis for multivariate analysis) were performed in order to evaluate the relationships between 18 F-FDG PVC-SUV BW and biopsy-evaluated histotype (signet ring cell carcinoma (SR), squamous cell carcinoma (S) and other adenocarcinoma (ADK) subtype) and grade (G1, G2, G3) (according to WHO and Lauren classifications).
Results

18
F-FDG PET/CT was able to detect gastric and gastrooesophageal cancer with a sensitivity of 82%: 18 F-FDG PET/CT images of 9 (18%) biopsy-proven gastric cancers were classified as negative, showing no 18 F-FDG uptake in the primitive lesions. Negative PET images were not quantified and were excluded by correlation analysis.
Mean primitive lesion diameter (sphere-equivalent diameter) was 2.15 ± 1.17 cm, ranging from 0.99 cm to 6.25 cm. Lesion size confirmed the need of PVC for accurate PET quantification for more than 75% of lesions [2] .
Signet ring cell carcinomas showed a lower 18 F-FDG PVC-SUV BW compared to squamous cell carcinomas and to other adenocarcinoma subtypes (PVC-SUV BW : 5.57 ± 3.22 g/cc vs 9.90 ± 1.91 g/cc vs 9.32 ± 4.26 g/cc; Mann-Whitney test, p < 0.05). No correlation was found when PVC was not applied to SUV BW Figure 1 shows the results for univariate analysis. The pre-processing k-means cluster analysis allowed to stratify patients in three different groups on the basis of PVC-SUV BW (PVC-SUV BW ≤ 6.25 g/cc; 6.25g/cc < PVC-SUV BW < 11.60 g/cc; PVC-SUV BW ≥ 11.60 g/cc). Using these groups, the hierarchical cluster analysis performed on PVC-SUV BW , histotype and grade showed that poorly differentiated (G3) signet ring cell carcinomas were significantly associated with 18 F-FDG PVC-SUV BW ≤ 6.25 g/cc (p < 0.05), while moderately differentiated (G2, G1) squamous cell carcinoma were significantly associated with 18 F-FDG PVC-SUV BW > 11.6 g/cc; (p < 0.05). Figure 2 shows the results of the hierarchical cluster analysis.
Discussion
The role of 18 F-FDG PET in staging gastric and gastroesophageal cancer is controversial. Some works showed a good sensitivity (94%) in the detection of primary gastric and gastro-oesophageal lesions [5] , while other studies softened the impact of 18 F-FDG PET [6] highlighting in particular its low sensitivity for signet-ring cells carcinomas [7] .
In current clinical practice, the election modalities for gastric and gastro-oesophageal cancer remains Endoscopic Ultrasound (EUS) and Computerized Tomography (CT), even if 18 F-FDG PET has been suggested in the work-up of patients with incomplete staging as obtained by EUS [5, 6] and for detection of distant metastases.
Although obtained in limited population of patients with gastric and gastro-oesophageal cancer, our results show that PVC-SUV BW can have a prognostic role for those lesions detected by 18 F-FDG PET. In literature, few works have been devoted to investigate the relationship between 18 F-FDG uptake, as detected and measured by PET, and tumour biological characteristics of gastro-oesophageal lesions [8, 9] . In published studies no correction for PVC has been used prior to the measurement of 18 F-FDG uptake. No correlation was found between 18 F-FDG uptake and the differentiation grade [9] , neither between 18 F-FDG uptake and histological type [8] , as obtained in our work when PVC was not applied to SUV BW .
Results of our work suggest that correlations can be found when PVC is applied.
Our work gives added value to current evidences on the role of 18 F-FDG in gastric and gastro-oesophageal cancer in adopting, for the first time at our knowledge, two strategies: 1) the application of PVC for the accurate measurement of 18 F-FDG SUV BW of small lesions and 2) the use of a multivariate hierarchic cluster analysis combined to a k-means pre-clustering approach for multiple correlations.
Our results need to be validated on a larger cohort of patients.
Conclusion
18 F-FDG PET can provide information on biological characteristics of gastric and gastro-oesophageal cancer by means of 18 F-FDG SUV on condition that partial volume correction is properly applied prior to the measurement of PET quantification indexes.
